4D Molecular Therapeutics Chief Medical Officer Robert Fishman receives $3.3M in 2020
4D Molecular Therapeutics reports 2020 executive compensation
By ExecPay News
Published: April 6, 2021
4D Molecular Therapeutics reported fiscal year 2020 executive compensation information on April 6, 2021.
In 2020, three executives at 4D Molecular Therapeutics received on average a compensation package of $1.6M, a 16% increase compared to previous year.
Average pay of disclosed executives at 4D Molecular Therapeutics
Robert Fishman, Chief Medical Officer, received $3.3M in total. 94% of Fishman's compensation, or $3.2M, was in option awards. Fishman also received $50K in bonus, $45K in non-equity incentive plan, as well as $90K in salary.
David Kirn, Chief Executive Officer, received a compensation package of $702K, which increased by 27% compared to previous year. 64% of the compensation package, or $451K, was in salary.
August Moretti, Chief Financial Officer, earned $633K in 2020, a 70% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 6, 2021.